|

Rezpegaldesleukin Clinical Trials

1 actively recruiting trial across 1 location

Also known as: NKTR-358

Pipeline

Phase 2: 1

Top Sponsors

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1

Indications

  • Type 1 Diabetes Mellitus1
  • Diabetes1

Pittsburgh, Pennsylvania1 trial

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

University of Pittsburgh

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.